Overexpression of the death-promoting gene bax-α which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice

Journal of Clinical Investigation

Volumn 97, Issue 11, 1996, Pages 2651-2659

  Bargou, Ralf C ^a,b   Wagener, Christian ^a   Bommert, Kurt ^a   Mapara, Markus Y ^a,b   Daniel, Peter T ^a,b   Arnold, Wolfgang ^a   Dietel, Manfred ^c   Guski, Hans ^c   Feller, Alfred ^d   Royer, Hans D ^a   Dörken, Bernd ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

APO I Fas; bcl 2 family; epithelium; malignancies; mammary gland

Indexed keywords

DNA FRAGMENT; MESSENGER RNA; TETRACYCLINE;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CONTROLLED STUDY; ETIOLOGY; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; SCID MOUSE; SEQUENCE HOMOLOGY;

EID: 8944230657     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118715     Document Type: Article

References (48)

1. Ellis, R.E., J.Y. Yuan, and H.R. Horvitz. 1991. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7:663-698.
2. Vaux, D.L., S. Cory, and J.M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond). 335:440-442.
3. Tsujimoto, Y., L.R. Finger, J. Yunis, P.C. Nowell, and C.M. Croce. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science (Wash. DC). 226:1097-1099.
4. Tsujimoto, Y., J. Gorham, J. Cossman, E. Jaffe, and C.M. Croce. 1985. The 1(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science (Wash. DC). 299:1390-1393.
5. Tsujimoto, Y., and C.M. Croce. 1986. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA. 83:5214-5218.
6. Tsujimoto, Y., N. Ikegaki, and C.M. Croce. 1987. Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene. 2:3-7.
7. Krammer, P.H., I. Behrmann, P.T. Daniel, J. Dhein, and K.M. Debatin. 1994. Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6: 279-289.
8. Sandford, N.L., J.W. Searle, and J.F. Kerr. 1984. Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation. Pathology. 16:406-410.
9. Tenniswood, M.P., R.S. Guenette, J. Lakins, M. Mooibroek, P. Wong, and J.E. Welsh. 1992. Active cell death (ACD) in hormone-dependent tissues. Cancer Metastasis Rev. 11:197-220.
10. Walker, N.I., R.E. Bennett, and J.F. Kerr. 1989. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat. 185:19-32.
11. Marti, A., B. Jehn, E. Costello, N. Keon, G. Ke, F. Martin, and R. Jaggi. 1994. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene. 9:1213-1223.
12. Lefebvre, O., C. Wolf, J.M. Limacher, P. Hutin, C. Wendung, M. LeMeur, P. Basset, and M.C. Rio. 1992. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J. Cell Biol. 119:997-1002.
13. Shaw, P., R. Bovery, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor derived cell line. Proc. Natl. Acad. Sci. USA. 89:5214-5218.
14. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.). 352:345-347.
15. Miyashita, T., and J. Reed. 1995. Tumor suppressor p53 is direct transcriptional activator of the human bax gene. Cell 80:293-299.
16. Miyashita, T., S. Krajewski, M. Krajewski, H.G. Wang, H.K. Lin, D.A. Liebermann, B. Hoffmann, and J.C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1799-1805.
17. Miyashita, T., M. Harigai, M. Hanada, and J.C. Reed. 1994. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 12:3133-3135.
18. Trauth, B.C., C. Klas, A.M. Peters, S. Matzku, P. Möller, W. Falk, K.M. Debatin, and P.H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Wash. DC). 245:301-305.
19. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp. Med. 169:1747-1756.
20. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. LiWeber, S. Richards, J. Dhein, B.C. Trauth, et al. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF/NGF receptor superfamily. J. Biol. Chem. 267:10709-10716.
21. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66: 233-243.
22. Dhein, J., P.T. Daniel, B.C. Trauth, A. Oehm, P. Möller, and P.H. Krammer. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149:3166-3173.
23. Daniel, P.T., and P.H. Krammer. 1994. Activation induces sensitivity towards APO-1 (CD95) mediated apoptosis in human B cells. J. Immunol. 153: 800-810.
24. Leithäuser, F., J. Dhein, G. Mechtersheimer, K. Koretz, K. Brüderlein, C. Henne, A. Schmidt, K.M. Debatin, P.H. Krammer, and P.H. Möller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415-429.
25. Nunez, G., L. London, D. Hockenbery, M. Alexander, J.P. McKearn, and S.J. Korsmeyer. 1990. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144:3602-3610.
26. Boise, L.H., M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson. 1993. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74: 597-608.
27. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609-619.
28. Apte, S.S., M.G. Mattet, and B.R. Olsen. 1995. Mapping of the human bax gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, bax-delta. Genomics. 26:592-594.
29. Russel, D.L., L. Kaklamanis, F. Pezzella, K.C. Gatter, and A.L. Harris. 1994. Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br. J. Cancer. 69:135-139.
30. Gasparini, G., M. Barbareschi, C. Doglioni, P.D. Palm, F.A. Mauri, P. Boracchi, P. Bevilacqua, O. Caffo, L. Morelli, P. Verderio, et al. 1995. Expression of Bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin. Cancer Res. 1:189-198.
31. Silvestrini, R., S. Veneroni, M.G. Daidone, E. Benini, P. Boracchi, M. Mezzetti, G. Di-Fronzo, F. Rilke, and U. Veronesi. 1994. The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J. Natl. Cancer Inst. 86:499-504.
32. Bargou, R.C., P.T. Daniel, M.Y. Mapara, K. Bommert, C. Wagener, B. Kallinich, H.D. Royer, and B. Dörken. 1995. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-α expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer. 60:854-859.
33. Walker, K.J., N. Bouzubar, J.F.R. Robertson, I.O. Ellis, C.W. Elston. R.W. Blamey, D.W. Wilson, K. Griffiths, and R.I. Nicholson. 1988. Immunocytochemical localization of estrogen receptor in human breast tissue. Cancer Res. 48:6517-6522.
34. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:5547-5551.
35. Ritter, K., H. Stöpfer, M. Pawlita, and G. Sczakiel. 1991. Versatile eucaryotic vectors for strong and constitutive transient and stable gene expression. Methods Mot. Cell. Biol. 2:176-181.
36. Wang, A.M., M.V. Doyle, and D.F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:9717-9720.
37. Deleted in proof.
38. Miltenyi, S., W. Müller, W. Weichel, and A. Radbruch. 1990. High gradient magnetic cell separation with MACS. Cytometry. 11:231-238.
39. Thor, A.D., D.H. Moore, and S.M. Edgerton. 1992. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J. Natl. Cancer Inst. 330:1260-1266.
40. Sabourin, J.C., A. Martin, J. Baruch, J.B. Truc, A. Gompel, and P. Poitout. 1994. bcl-2 expression in normal tissue during the menstrual cycle. Int. J. Cancer. 59:1-6.
41. Krajewski, S., C. Blomqvist, K. Franssila, M. Krajewski, V.-M. Wasenius, E. Niskanen, S. Nordling, and J.C. Reed. 1995. Reduced expression of proapoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55:4471-4478.
42. McDonnell, T.J., and S.J. Korsmeyer. 1991. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature (Lond.). 349:254-256.
43. Pezzella, F., H. Turley, I. Kuzu, M.F. Tungekar, M.S. Dunnill, C.B. Pierce, A. Harris, K.C. Gatter, and D.Y. Mason. 1993. Bcl-2 protein in non-small-cell lung carcinoma. N. Engl J. Med. 329:690-694.
44. Wafik, S.E.-D., J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang, et al. 1994. WAF/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54: 1169-1174.
45. Mapara, M., R. Bargou, C. Zugck, H. Dönner, F. Ustaoglu, P.H. Krammer, and B. Dörken. 1993. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23:702-708.
46. Owen-Schaub, L., R. Radinsky, E. Kruzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on nonhematopoetic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54:1580-1586.
47. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621-627.
48. Takayama, S., T. Sato, S. Krajewski, K. Kochel, S. Irie, J. Millan, and J. Reed. 1995. Cloning and functional analysis of BAG-1: a novel bcl-2-binding protein with anti-cell death activity. Cell. 80:279-284.